Veradermics (MANE) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
-3522.1%

Only 1 fiscal year of return on invested capital is on record here for Veradermics (MANE); a history needs at least 3. Figures as of 18 Nov 2026, 02:35 UTC, from Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
-3522.1%
Fiscal years on record
12025–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of return on invested capital needs at least 3 fiscal years; one is on record here for Veradermics. Nothing is estimated to fill the gap. What is on record is in the table below.

Veradermics return on invested capital (ROIC), year by year

Veradermics (MANE) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
2025-3522.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Veradermics and comparable companies
CompanyReturn on invested capitalFiscal year
Scholar Rock Holding SRRK-1906.5%2023
Teleflex TFX4.7%2025
Mirum Pharmaceuticals MIRM-7.0%2025
Veradermics MANE-3522.1%2025
Grifols GRFS7.3%2025
Cogent Biosciences COGT-1502.3%2023

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics return on invested capital (ROIC): questions and answers

How is Veradermics's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/MANE/roic

Underlying data: Yahoo Finance.